scholarly journals A case of successful percutaneous mitral valve repair for refractory heart failure due to myocardial infarction complicated with severe ischemic mitral regurgitation

2021 ◽  
Vol 28 (5) ◽  
pp. 463-464
Author(s):  
Shunsuke Saga ◽  
Masao Imai ◽  
Tadashi Miyamoto ◽  
Akihiko Miyata ◽  
Takashi Kuragaichi ◽  
...  
2020 ◽  
Vol 21 (1) ◽  
pp. 52-60 ◽  
Author(s):  
Tomás Benito-González ◽  
Rodrigo Estévez-Loureiro ◽  
Pedro A. Villablanca ◽  
Patrizio Armeni ◽  
Ignacio Iglesias-Gárriz ◽  
...  

2015 ◽  
Vol 68 (3) ◽  
pp. 259-261
Author(s):  
Miguel Rodríguez-Santamarta ◽  
Rodrigo Estévez-Loureiro ◽  
Javier Gualis ◽  
David Alonso ◽  
Armando Pérez de Prado ◽  
...  

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Alberto Polimeni ◽  
Michele Albanese ◽  
Nadia Salerno ◽  
Iolanda Aquila ◽  
Jolanda Sabatino ◽  
...  

Abstract Percutaneous mitral valve repair has been increasingly performed worldwide after approval. We sought to investigate predictors of clinical outcome in patients with mitral regurgitation undergoing percutaneous valve repair. The MITRA-UMG study, a single-centre registry, retrospectively collected consecutive patients with symptomatic moderate-to-severe or severe MR undergoing MitraClip therapy. The primary endpoint was the composite of cardiovascular death or rehospitalization for heart failure. Between March 2012 and July 2018, a total of 150 consecutive patients admitted to our institution were included. Procedural success was obtained in 95.3% of patients. The composite primary endpoint of cardiovascular death or rehospitalization for HF was met in 55 patients (37.9%) with cumulative incidences of 7.6%, 26.2%, at 30 days and 1-year, respectively. In the Cox multivariate model, NYHA functional class and left ventricular end-diastolic volume index (LVEDVi), independently increased the risk of the primary endpoint at long-term follow-up. At Kaplan–Meier analysis, a LVEDVi > 92 ml/m2 was associated with an increased incidence of the primary endpoint. In this study, patients presenting with dilated ventricles (LVEDVi > 92 ml/m2) and advanced heart failure symptoms (NYHA IV) at baseline carried the worst prognosis after percutaneous mitral valve repair.


2015 ◽  
Vol 21 (10) ◽  
pp. S157
Author(s):  
Yukiko Mizutani ◽  
Shunsuke Kubo ◽  
Makar Moody ◽  
Mamoo Nakamura ◽  
Takahiro Shiota ◽  
...  

2016 ◽  
Vol 68 (18) ◽  
pp. B261-B262
Author(s):  
Rodrigo Estevez ◽  
Tomas Benito-González ◽  
Javier Gualis-Cardona ◽  
Laura Romero-Roche ◽  
Carlota Hernandez ◽  
...  

2014 ◽  
Vol 41 (3) ◽  
pp. 312-315 ◽  
Author(s):  
Kerim Cagli ◽  
Hikmet Selcuk Gedik ◽  
Kemal Korkmaz ◽  
Baran Budak ◽  
Umit Yener ◽  
...  

Transventricular mitral valve surgery combined with left ventricular restoration avoids atriotomy and provides a larger operative field. We describe a series of 5 patients in whom we performed transventricular mitral valve repair by various techniques, such as band annuloplasty, papillary muscle reattachment, chordal cutting, and edge-to-edge repair. The more acute forms of ischemic mitral regurgitation, as found in our patients, can coexist with post-myocardial infarction contained rupture or post-myocardial infarction ventricular septal rupture. Because these patients already have an indication for ventriculotomy, concomitant transventricular repair of the mitral valve can render a separate atriotomy unnecessary and thereby shorten the duration of cardiopulmonary bypass. Moreover, in patients with acute presentations, the absence of atrial dilation (this last associated with chronic cases) might make transventricular repair a better choice than the more difficult atrial approach.


2015 ◽  
Vol 66 (1) ◽  
pp. 91-92 ◽  
Author(s):  
Rodrigo Estévez-Loureiro ◽  
Dabit Arzamendi ◽  
Xavier Freixa ◽  
Rosa Cardenal ◽  
Fernando Carrasco-Chinchilla ◽  
...  

2003 ◽  
Vol 60 (3) ◽  
pp. 410-416 ◽  
Author(s):  
John R. Liddicoat ◽  
Briain D. Mac Neill ◽  
A. Marc Gillinov ◽  
William E. Cohn ◽  
Chi-Hui Chin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document